Key result
Chios mastic gum reduces viral replication and mortality in IAV-infected mice by blocking early infection.
Why the study?
Little is known about Chios mastic gum's antiviral activity, despite its known influence on cellular processes and the dependence of viral replication on host metabolism.
Does Chios mastic gum inhibit influenza A virus replication and reduce viral pathogenicity in preclinical models?
Does Chios mastic gum inhibit influenza A virus replication and reduce viral pathogenicity in preclinical models?
Chios mastic gum demonstrates potent antiviral activity against influenza A virus by blocking the early stage of viral replication in preclinical models.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for Chios mastic gum in influenza; human trials required before any clinical consideration.
var. chia), has been used to treat multiple disorders caused by gastrointestinal malfunctions and bacterial infections for more than 2500 years. However, little is known about CMG's antiviral activity. CMG is known to influence multiple cellular processes such as cell proliferation, differentiation and apoptosis. As virus replication is largely dependent on the host cellular metabolism, it is conceivable that CMG regulates virus infectivity. Therefore, in this study, we evaluated CMG's potential as an antiviral drug to treat influenza A virus (IAV) infection. CMG treatment dramatically reduced the cytopathogenic effect and production of RNAs, proteins and infectious particles of IAV. Interestingly, CMG interfered with the early stage of the virus life cycle after viral attachment. Importantly, the administration of CMG greatly ameliorated morbidity and mortality in IAV-infected mice. The results suggest that CMG displays a potent anti-IAV activity by blocking the early stage of viral replication. Thus, mastic gum could be exploited as a novel therapeutic agent against IAV infection.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2021) studied Influenza A virus (IAV) infection. Chios mastic gum (CMG) was evaluated on Viral replication, morbidity, and mortality. Chios mastic gum treatment reduced viral replication and ameliorated morbidity and mortality in IAV-infected mice by blocking the early stage of the virus life cycle.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: